AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Eledon Pharmaceuticals In... (ELDN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.79

0.08 (2.16%)

At close: Jan 15, 2025, 10:00 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	n/a	n/a	n/a	120.00K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	374.00K	373.00K	195.00K	183.00K	182.00K	11.00K	22.00K	35.00K	109.00K	58.00	n/a	n/a
Gross Profit	-374.00K	-373.00K	-195.00K	-63.00K	-182.00K	-11.00K	-22.00K	-35.00K	-109.00K	-58	n/a	n/a
Operating Income	-43.00M	8.49M	-36.87M	-18.46M	-16.05M	-14.06M	-13.12M	-38.12M	-45.26M	-23.46M	-15.75M	-9.65M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-40.33M	-87.97M	-36.86M	-23.21M	-16.01M	-14.06M	-13.12M	-37.96M	-45.09M	-23.30M	-15.72M	-9.65M
Net Income	-40.33M	-87.50M	-34.51M	-22.81M	-17.88M	-14.06M	-13.12M	-37.96M	-45.09M	-23.30M	-15.72M	-9.65M
Selling & General & Admin	12.69M	12.70M	13.13M	10.05M	6.06M	7.24M	11.10M	13.10M	12.62M	8.88M	3.55M	2.28M
Research & Development	30.31M	27.08M	23.73M	6.13M	8.13M	6.82M	2.02M	25.02M	32.64M	14.58M	12.20M	7.37M
Other Expenses	n/a	462.00K	7.00K	79.00K	40.00K	-5.00K	5.00K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	43.00M	39.78M	36.87M	16.18M	14.18M	14.06M	13.12M	38.12M	45.26M	23.46M	15.75M	9.65M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174.00K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	43.00M	39.78M	36.87M	16.18M	14.18M	14.06M	13.12M	38.12M	45.26M	23.46M	15.75M	9.65M
Income Tax	n/a	-462.00K	-2.35M	-404.00K	1.87M	-5.00K	n/a	136.00K	n/a	-187.00K	n/a	n/a
Shares Outstanding (Basic)	24.62B	14.29M	14.82M	1.45M	655.52K	500.30K	259.87K	21.26K	138.79K	39.93K	94.80K	94.80K
Shares Outstanding (Diluted)	24.62M	14.29M	14.82M	1.45M	655.52K	500.30K	259.87K	21.26K	138.79K	39.93K	94.80K	94.80K
EPS (Basic)	-0.00	-6.13	-2.33	-15.72	-27.27	-28.11	-50.47	-1.79K	-324.85	-583.36	-165.87	-101.78
EPS (Diluted)	-1.64	-6.13	-2.33	-15.72	-27.27	-28.11	-50.47	-1.79K	-324.85	-583.36	-165.87	-101.78
EBITDA	n/a	-87.59M	-36.66M	-23.03M	-15.83M	-14.05M	-13.10M	-6.90M	-44.98M	-23.27M	-15.71M	-9.64M
Depreciation & Amortization	43.00M	373.00K	195.00K	183.00K	182.00K	11.00K	22.00K	35.00K	109.00K	21.00K	10.00K	9.00K